The global enteric disease testing market is anticipated to grow at a CAGR of 3.2% during the forecast period. The increasing prevalence of enteric disease infections with a lack of proper sanitation is significantly contributing to the growth of the enteric disease testing market. According to the World Health Organization (WHO), salmonella is one of the major causes of diarrhoeal diseases across the globe. Due to the consumption of unsafe food people gets diarrhoeal diseases which are the most common illnesses, due to which around 550 million people fall ill each year. According to the Centers for Disease Control and Prevention (CDC), salmonella bacteria cause around 1.35 million infections, with 26,500 hospitalization and 420 mortalities in the US every year.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/enteric-disease-testing-market
Additionally, according to, the CDC around 11 to 20 million cases of typhoid fever and 2,00,000 mortalities occur across the globe each year around 350 patients are diagnosed with typhoid fever, and 90% of people are diagnosed with paratyphoid fever every year. Each year around 1.4 to 4 million cases of cholera are detected and around 21,000 to 143,000 mortalities are recorded across the globe. This rising number of enteric disease cases is resulting in increasing demand for enteric disease testing. Asia-Pacific is also expected to witness significant growth in the market. The rising prevalence of cholera and rising awareness regarding such disorders is primarily contributing to the market growth in the region. The three largest cholera endemic countries across the globe include India, China, and Indonesia. This, in turn, is driving the demand for enteric disease testing in the region.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Pathogen Tested
o By Technology
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Bio-Rad Laboratories, Inc., Abbott Laboratories, Quest Diagnostics, BioMerieux SA, and Meridian Bioscience, Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Enteric Disease Testing Market Report by Segment
By Pathogen Tested
- E.Coli
- Salmonella
- Campylobacter
- Listeria
By Technology
- Traditional
- Rapid
- Polymerase Chain Reaction (PCR)
- Immunoassay
- Chromatography & spectrometry
By End-User
- Water
- Food
A full report of Enteric Disease Testing Market is available at: https://www.omrglobal.com/industry-reports/enteric-disease-testing-market
Enteric Disease Testing Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AsureQuality Ltd.
- Becton, Dickinson and Company (BD)
- Certified Laboratories Inc.
- Coris BioConcept SPRL
- Eurofins Scientific
- Hardy Diagnostics
- Intertek Group plc
- Merck Group (Merck KGaA)
- Mérieux NutriSciences Corp
- Neogen Corp
- Nova Biologicals
- PerkinElmer, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
